Toludesvenlafaxine clinical trials
Also written LY03005.
How each study uses toludesvenlafaxine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the toludesvenlafaxine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2024 (3)
| Year | Studies |
|---|---|
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 9 · Other 6
Luye Pharma Group Ltd. (9) · Shanghai Mental Health Center (2) · Beijing Tiantan Hospital (2) · First Affiliated Hospital of Zhejiang University (1) · Jiangsu Province Nanjing Brain Hospital (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test toludesvenlafaxine.
- Feb 2027To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release TabletsPhase 4 · Luye Pharma Group Ltd.
- Jun 2027The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With FibromyalgiaNot applicable · Beijing Tiantan Hospital
Studies
Open first, then newest update. How each study uses toludesvenlafaxine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Toludesvenlafaxine for Non-specific Low Back PainRecruitingNot applicableBeijing Tiantan HospitalNCT07709416Written as ToludesvenlafaxineHow we know
- The Efficacy and Safety of Pregabalin Combined With Toludesvenlafaxine in Patients With FibromyalgiaRecruitingNot applicableBeijing Tiantan HospitalNCT07208357Written as Pregabalin with toludesvenlafaxineHow we know
- To Evaluate the Long-term Efficacy and Safety of Toludevenlafaxine Hydrochloride Sustained-release TabletsNot yet recruitingPhase 4Luye Pharma Group Ltd.NCT06426485Written as Toludesvenlafaxine Hydrochloride Sustained-release TabletsHow we know
- Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression DisorderRecruitingNot applicableJiangsu Province Nanjing Brain HospitalNCT06270433Written as Toludesvenlafaxine hydrochloride sustained-release tabletsHow we know
- Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)RecruitingPhase 4Shanghai Mental Health CenterNCT06026917Written as Toludesvenlafaxine hydrochloride sustained-release tabletsHow we know
- Efficacy and Safety of Toluedesvenlafaxine Hydrochloride Extended-release Tablets in Somatic Symptoms of DepressionCompletedPhase 4Shanghai Mental Health CenterNCT05849272Written as toludesvenlafaxine hydrochloride sustained-release tabletsHow we know
- Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Venlafaxine Hydrochloride Sustained-release Tablets in Patients With Major Depression DisorderCompletedNot applicableFirst Affiliated Hospital of Zhejiang UniversityNCT06278038Written as Toludesvenlafaxine hydrochloride sustained-release tabletsHow we know
- A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedPhase 3Luye Pharma Group Ltd.NCT04853407Written as LY03005 extended-release tabletHow we know
- A Relative Bioavailability Food Effect Study of LY03005CompletedPhase 1Luye Pharma Group Ltd.NCT03822065Written as LY03005How we know
- Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedPhase 1Luye Pharma Group Ltd.NCT03785652Written as LY03005 extended-release tablets 40 mgHow we know
- A Study of LY03005 vs PristiqCompletedPhase 1Luye Pharma Group Ltd.NCT03733574Written as LY03005How we know
- Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®CompletedPhase 1Luye Pharma Group Ltd.NCT03357796Written as LY03005How we know
- Pilot BA Study of New LY03005 vs PristiqCompletedPhase 1Luye Pharma Group Ltd.NCT02988024Written as LY03005How we know
- Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005CompletedPhase 1Luye Pharma Group Ltd.NCT02271412Written as LY03005How we know
- Safety, Tolerability and Pharmacokinetics Study of LY03005CompletedPhase 1Luye Pharma Group Ltd.NCT02055300Written as LY03005How we know
Codes
What other systems call toludesvenlafaxine · ClinicalTrials.gg INT015982
- UNII (FDA) A7CGH459FNTOLUDESVENLAFAXINEOne source FDA
- NCI Thesaurus C171708ToludesvenlafaxineOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | A7CGH459FN | TOLUDESVENLAFAXINE | One source FDA |
| NCI Thesaurus | C171708 | Toludesvenlafaxine | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.